Join the Oncology
Community
Follow Us:  
Practice Trends
Liability Reform: A Broken Promise?

Republicans on the House Energy & Commerce Committee took President Obama to task on Tuesday in a short video that ... »

Cancer Screening Falls Short of Federal Targets

U.S. cancer screening rates in 2010 were below national targets for 2020, particularly among Asians and Hispanics, according... »

Medicare, Medicaid, Tort Reform in Play in Florida Primary

Although the Republican primaries this year have been anything but predictable, one thing is fairly certain: Health care... »

More Practice Trends »

Cancer Prevention and Epidemiology
Oral HPV Infection More Prevalent in Men Than Women

The prevalence of oral human papillomavirus is nearly three times higher in men than in women, according to data from more... »

The Top 10 Stories on OncologyReport.com in 2011

Catch up with what you missed as we count down the 10 most-read online stories from The Oncology Report in 2011.  »

Old Antivirals Rival New for Cancer Prevention in Hepatitis B

SAN FRANCISCO – Older and newer oral antiviral agents are similarly effective at preventing hepatocellular carcinoma in... »

More Cancer Prevention & Epidemiology News »

Multimedia
Videos

Sharing bad news with patients or their families can be challenging, but doing it well is a skill that physicians can learn and master, Dr. James Avery says.

Slideshow
The emerging role for PARP inhibitors in BRCA-mutated cancers is reviewed by Community Oncology Editor-in-Chief Dr. Lee Schwartzberg.
Podcasts
The Policy & Practice Podcast covers health care regulation and reform for physicians.
Patient & Survivor Care
Prostate Cancer Deaths: Annual Screen Not Superior to Usual Care

After 13 years of follow-up, men who underwent annual screening for prostate cancer were no less likely to die of prostate... »

IGF-I Doesn't Predict Late Complications in Childhood Cancer Survivors

SAN DIEGO –Insulinlike growth factor I level was not useful as a marker of growth hormone deficiency or altered body... »

MRI Identifies Candidates for Prostate Cancer Surveillance

CHICAGO – Multiparametric magnetic resonance imaging trumped national guidelines in correctly classifying patients with... »

More Patient & Survivor Care »

In the Pipeline
FDA Approves Subcutaneous Bortezomib for Marketed Indications

The Food and Drug Administration has approved a subcutaneous formulation of bortezomib, which will join the intravenous... »

Brivanib Disappoints in KRAS Wild-Type Colorectal Cancer

SAN FRANCISCO – Eagerly awaited results of the CO.20 trial in metastatic chemorefractory KRAS wild-type colorectal cancer... »

Gastric Cancer Subtype May Affect Bevacizumab Benefit

SAN FRANCISCO – The benefit of bevacizumab in some patients with advanced gastric cancer appears to vary by disease subtype,... »

In the Pipeline »

Views

 What Matters
CLEOPATRA: Success With Dual HER2 Blockade in Breast Cancer

SAN ANTONIO – Dr. Howard A. Burris III, Dr. William J. Gradishar, and Dr. Hope S. Rugo remark on the implications of the... »


Betsy Bates Freed, Psy.D.
 Vitality Signs
Burnout in Oncology

Long before it was applied to people, the term “burnout” appeared in Merriam-Webster’s Dictionary to describe what happened... »

Blognosis Blognosis
Liability Reform: A Broken Promise?

Republicans on the House Energy & Commerce Committee took President Obama to task on Tuesday in a short video that ... »


Commentaries
 Commentaries
Defending Your Online Reputation

Have you ever run across a negative or even malicious comment about you or your office on the Web, in full view of the... »

Clinical News
FDA Approves Axitinib for Advanced Kidney Cancer

Axitinib, a kinase inhibitor, received approval for the treatment of advanced renal cell cancer and is the seventh drug... »

Erlotinib Dose Doubled for Smokers With Head/Neck Cancer

PHOENIX – Giving smokers a higher, short-course dose of erlotinib before definitive surgery for squamous cell carcinoma of... »

Malignancy Rates Remain Stable in Ustekinumab-Treated Patients

RIO GRANDE, P.R. – Malignancy rates in psoriasis patients treated with ustekinumab did not increase significantly over 4... »

Head/Neck Cancer Treatments Less Effective in HIV Patients

PHOENIX – Definitive radiation therapy with or without chemotherapy was less tolerated and less effective in HIV-positive... »

Feds Bar Generic Drug Maker Ranbaxy

Generic drug manufacturer Ranbaxy Laboratories Ltd. will have to withdraw all drug applications that contain data generated... »

More Clinical News »

Current Issue


The Oncology Report Comprehensive reports and expert commentary on the latest advances in cancer treatment from the world's major oncology meetings.

Past issues, click here »


calendar
Jan 26 - 28
San Francisco, CA		 Jonathan Wood & Associates: T-cell Lymphoma Forum
Jan 26 - 28
Phoenix, AZ		 American Society for Radiation Oncology (ASTRO): Multidisciplinary Head and Neck Cancer Symposium
Jan 31 - Feb 2
Paris, 		International Congress on Anti-Cancer Treatment (ICACT)
Feb 2 - 4
San Francisco, CA		 American Society of Clinical Oncology (ASCO): Genitourinary Cancers Symposium
Feb 6 - 9
Orlando, FL		 American Association for Cancer Research (AACR): Advances in Prostate Cancer Research
Feb 23 - 25
Miami, FL		 American Psychosocial Oncology Society (APOS): Annual Conference
Mar 3 - 6
Washington, DC		 American Society of Preventive Oncology (ASPO): Annual Meeting
Mar 12 - 14
Baltimore, MD		 Association of Community Cancer Centers (ACCC): Annual National Meeting
Mar 14 - 18
Hollywood, FL		 National Comprehensive Cancer Network (NCCN): Annual Conference: Clinical Practice Guidelines & Quality Cancer Care
Mar 17 - 20
Gdansk, 		European Society for Medical Oncology (ESMO)/ European Society for Therapeutic Radiology and Oncology (ESTRO): Combined Drug-Radiation Treatment
More Calendar »